Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1
Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,222 | Dovepress* | 7,222+ | 1,878 | 9,100 | |
Totals | 7,222 | 1,878 | 9,100 | ||
*Since 15 March 2007 +Since July 2016 |
View citations on Google Scholar